Harvard Bioscience COO Ken Olson resigns, enters separation agreement

HARVARD BIOSCIENCE INC

Ken Olson resigned as COO effective January 31, 2022 for personal reasons.
Separation agreement signed Jan 26, 2022 provides salary through Dec 31, 2022.
Olson will provide remote assistance on projects and transition of duties until Dec 31, 2022.
Resignation was not due to any disagreement with company operations, policies, or practices.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ken Olson

Chief Operating Officer

HBIO · HARVARD BIOSCIENCE INC

Effective: 2022-01-31
Filed: January 28, 2022, 6:59 PM ET

On January 24, 2022, Harvard Bioscience, Inc. (the “Company”) accepted the resignation of Ken Olson for personal reasons from his position as Chief Operating Officer of the Company effective January 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ken Olson resigned as Chief Operating Officer at HARVARD BIOSCIENCE INC.

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On January 24, 2022, Harvard Bioscience, Inc. (the “Company”) accepted the resignation of Ken Olson for personal reasons from his position as Chief Operating Officer of the Company effective January 31, 2022.

View on SEC.gov

HARVARD BIOSCIENCE INC filing history →

Source: SEC EDGAR

accession 0001193805-22-000124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.